Source: PR Newswire

Press Release: Schrodinger : Schrödinger to Participate in Citi 13th Annual Biotech Conference

NEW YORK, Aug. 30, 2018 /PRNewswire/ -- Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced today that the Company will participate in a panel discussion entitled "Emerging Innovators - An Introduction...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Ramy Farid's photo - President & CEO of Schrodinger

President & CEO

Ramy Farid

CEO Approval Rating

88/100

Schrodinger develops a chemical simulation software that offers drug design and molecular modeling solutions for pharmaceutical and biotechnology companies. Read more